SpringWorks Therapeutics Inc (NAS:SWTX)
$ 41.48 -0.25 (-0.6%) Market Cap: 3.09 Bil Enterprise Value: 2.72 Bil PE Ratio: 0 PB Ratio: 5.79 GF Score: 38/100

SpringWorks Therapeutics Inc at TD Cowen Oncology Innovation Summit (Virtual) Transcript

May 31, 2023 / 05:00PM GMT
Release Date Price: $27.38 (-1.72%)
Yaron Werber
TD Cowen - Analyst

Well, terrific. Good afternoon, everybody, and welcome once again to the 4th Annual Oncology Innovation Summit. I'm Yaron Werber, one of the biotech analysts here at TD Cowen, and it's a great pleasure to moderate the next session with SpringWorks Therapeutics and Badreddin Edris, who is Chief Operating Officer. Badreddin, always good to see you. Thanks for joining us.

Badreddin Edris
SpringWorks Therapeutics, Inc. - COO

Likewise, Yaron. Thanks so much for hosting us.

Yaron Werber
TD Cowen - Analyst

So lots to talk about. And as always, if there's any questions, feel free to email them directly to me at [email protected]. Or you can log into the Wall Street Webcasting webpage here and go ahead and type your question, and I can definitely say it anonymously for you.

Questions & Answers

Yaron Werber
TD Cowen - Analyst

So I wanted to touch on, first of all, mirdametinib, lots going on with the ReNeu study now that

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot